These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23970369)

  • 1. Kinetic modeling, test-retest, and dosimetry of 123I-MNI-420 in humans.
    Tavares AA; Batis JC; Papin C; Jennings D; Alagille D; Russell DS; Vala C; Lee H; Baldwin RM; Zubal IG; Marek KL; Seibyl JP; Barret O; Tamagnan GD
    J Nucl Med; 2013 Oct; 54(10):1760-7. PubMed ID: 23970369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors.
    Barret O; Hannestad J; Vala C; Alagille D; Tavares A; Laruelle M; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2015 Apr; 56(4):586-91. PubMed ID: 25698783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
    Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain.
    Tavares AA; Batis J; Barret O; Alagille D; Vala C; Kudej G; Koren A; Cosgrove KP; Nice K; Kordower JH; Seibyl J; Tamagnan GD
    Nucl Med Biol; 2013 Apr; 40(3):403-9. PubMed ID: 23332393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Evaluation of an Adenosine A
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [No Abstract]   [Full Text] [Related]  

  • 6. Whole-body biodistribution and dosimetry estimates of a novel radiotracer for imaging of serotonin 4 receptors in brain: [¹⁸F]MNI-698.
    Tavares AA; Caillé F; Barret O; Papin C; Lee H; Morley TJ; Fowles K; Holden D; Seibyl JP; Alagille D; Tamagnan GD
    Nucl Med Biol; 2014; 41(5):432-9. PubMed ID: 24674817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
    Barret O; Hannestad J; Alagille D; Vala C; Tavares A; Papin C; Morley T; Fowles K; Lee H; Seibyl J; Tytgat D; Laruelle M; Tamagnan G
    J Nucl Med; 2014 Oct; 55(10):1712-8. PubMed ID: 25082853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.
    Catafau AM; Pérez V; Penengo MM; Bullich S; Danús M; Puigdemont D; Pascual JC; Corripio I; Llop J; Perich J; Alvarez E
    J Nucl Med; 2005 Aug; 46(8):1301-9. PubMed ID: 16085586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
    J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
    Naganawa M; Waterhouse RN; Nabulsi N; Lin SF; Labaree D; Ropchan J; Tarabar S; DeMartinis N; Ogden A; Banerjee A; Huang Y; Carson RE
    J Nucl Med; 2016 Sep; 57(9):1388-95. PubMed ID: 27103022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects.
    Lin KJ; Liu CY; Wey SP; Hsiao IT; Wu J; Fu YK; Yen TC
    Nucl Med Biol; 2006 Feb; 33(2):193-202. PubMed ID: 16546673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of 18F-MNI698: an 18F-labeled radiotracer for imaging of serotonin 4 receptors in brain.
    Tavares AA; Caillé F; Barret O; Papin C; Lee H; Morley TJ; Fowles K; Holden D; Seibyl JP; Alagille D; Tamagnan GD
    J Nucl Med; 2014 May; 55(5):858-64. PubMed ID: 24686782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
    Newberg AB; Plössl K; Mozley PD; Stubbs JB; Wintering N; Udeshi M; Alavi A; Kauppinen T; Kung HF
    J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.
    Staley JK; van Dyck CH; Weinzimmer D; Brenner E; Baldwin RM; Tamagnan GD; Riccardi P; Mitsis E; Seibyl JP
    J Nucl Med; 2005 Sep; 46(9):1466-72. PubMed ID: 16157529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans.
    Frokjaer VG; Pinborg LH; Madsen J; de Nijs R; Svarer C; Wagner A; Knudsen GM
    J Nucl Med; 2008 Feb; 49(2):247-54. PubMed ID: 18199621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
    Wong DF; Kuwabara H; Kim J; Brasic JR; Chamroonrat W; Gao Y; Valentine H; Willis W; Mathur A; McCaul ME; Wand G; Gean EG; Dannals RF; Horti AG
    J Nucl Med; 2013 Aug; 54(8):1308-14. PubMed ID: 23801676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.